Table 1.
Descriptive demographic and clinical features of the study groups
| AD-D | AD-MCI | HC | Test value; p | |
|---|---|---|---|---|
| N | 22 | 16 | 74 | – |
| Sex, N (M/F) | 10/12 | 11/5 | 31/43 | – |
| Age, mean ± SD | 72.18 ± 6.27 | 71.38 ± 10.53 | 67.15 ± 13.87 | F = 1.84; p = 0.16 |
| MMSE, mean ± SD* | 17.92 ± 6.70 | 26.88 ±1.20 | – | T = 4.75; p < 0.001 |
| CDR, mean ± SD* | 1.84 ± 0.77 | 0.50 ± 0.00 | – | T = −7.65; p < 0.001 |
Abbreviations: AD-D Alzheimer’s disease dementia, CDR Clinical Dementia Rating, HC healthy controls, AD-MCI MCI due to Alzheimer’s disease, MMSE Mini-Mental State Examination
*Neither MMSE nor CDR was available in 3 AD-D patients, who were tested by means of the Montreal Cognitive Assessment test (total MoCA score = 11; 12; 19, respectively)